Baird Financial Group’s Ingevity NGVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-5,152
Closed -$325K 1793
2022
Q2
$325K Buy
5,152
+16
+0.3% +$1.04K ﹤0.01% 1516
2022
Q1
$329K Sell
5,136
-178
-3% -$11.9K ﹤0.01% 1587
2021
Q4
$381K Hold
5,314
﹤0.01% 1582
2021
Q3
$379K Buy
+5,314
New +$419K ﹤0.01% 1587

Other funds holding NGVT

Baird Financial Group's NGVT Position: Q3 2022 in Review

Baird Financial Group sold out of Ingevity (NGVT) in Q3 2022, closing a stake of 5,152 shares — an estimated $325K sold.

Baird Financial Group first reported a position in NGVT in Q3 2021 and held it in 4 quarters. The position peaked at $381K in Q4 2021. 269 funds tracked by Wall St. Rank hold NGVT as of Q3 2022.

  • Baird Financial Group reported no remaining Ingevity position as of Q3 2022 after selling out during the quarter.
  • Baird Financial Group sold 5,152 Ingevity shares in Q3 2022, an estimated $325K.
  • Baird Financial Group first reported a position in Ingevity in Q3 2021 and held it in 4 quarters.
  • Baird Financial Group's Ingevity position peaked at $381K in Q4 2021.
  • 269 funds tracked by Wall St. Rank held Ingevity as of Q3 2022.

Based on Baird Financial Group's 13F filing for Q3 2022, filed 15 Nov 2022.